Encompass Health (NYSE:EHC) Price Target Increased to $108.00 by Analysts at Barclays

Encompass Health (NYSE:EHC - Free Report) had its target price increased by Barclays from $101.00 to $108.00 in a report issued on Thursday morning, Benzinga reports. Barclays currently has an overweight rating on the stock.

A number of other analysts have also recently issued reports on the stock. Stephens restated an overweight rating and set a $85.00 target price on shares of Encompass Health in a research note on Tuesday, January 16th. Mizuho raised their target price on shares of Encompass Health from $93.00 to $95.00 and gave the stock a buy rating in a research note on Thursday. Royal Bank of Canada restated an outperform rating and set a $83.00 target price on shares of Encompass Health in a research note on Friday, February 9th. Truist Financial raised their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a buy rating in a research note on Friday, February 9th. Finally, William Blair restated an outperform rating on shares of Encompass Health in a research note on Wednesday, February 7th. Eight equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Encompass Health currently has an average rating of Buy and a consensus target price of $85.44.

Encompass Health Stock Performance

EHC stock traded down $0.06 during trading hours on Thursday, reaching $82.74. The stock had a trading volume of 1,488,277 shares, compared to its average volume of 671,911. The stock has a market capitalization of $8.29 billion, a PE ratio of 23.84, a price-to-earnings-growth ratio of 1.53 and a beta of 0.94. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.28 and a quick ratio of 1.28. The stock has a 50-day simple moving average of $78.07 and a 200 day simple moving average of $70.76. Encompass Health has a fifty-two week low of $57.55 and a fifty-two week high of $85.84.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.19. The firm had revenue of $1.32 billion during the quarter, compared to analysts' expectations of $1.27 billion. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The company's revenue for the quarter was up 13.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.88 earnings per share. Analysts predict that Encompass Health will post 3.96 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 annualized dividend and a yield of 0.73%. Encompass Health's dividend payout ratio is currently 17.29%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. International Assets Investment Management LLC acquired a new position in Encompass Health during the fourth quarter valued at approximately $20,210,000. Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of Encompass Health by 2.3% during the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,318,784 shares of the company's stock worth $87,989,000 after buying an additional 29,926 shares in the last quarter. Phocas Financial Corp. increased its holdings in Encompass Health by 112.4% in the fourth quarter. Phocas Financial Corp. now owns 99,875 shares of the company's stock valued at $6,664,000 after purchasing an additional 52,847 shares during the period. Nordea Investment Management AB increased its holdings in Encompass Health by 21.0% in the fourth quarter. Nordea Investment Management AB now owns 101,705 shares of the company's stock valued at $6,787,000 after purchasing an additional 17,684 shares during the period. Finally, Oak Thistle LLC increased its holdings in Encompass Health by 19.1% in the fourth quarter. Oak Thistle LLC now owns 14,436 shares of the company's stock valued at $963,000 after purchasing an additional 2,319 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.